QR-koodi

COVID-19 in patients with haematologic malignancies: Effect of RNAemia on clinical outcome in vaccinated patients

Objectives: Patients with haematologic malignancies (HM) COVID-19 have more severe disease, with increased risk of mortality. Therefore, this study aimed to evaluate the effect of SARS-CoV-2 RNAemia and the specific humoral immune responses on the clinical outcomes of patients with HM and COVID-19....

Täydet tiedot

Tallennettuna:
Päätekijät: Javier Martín-Escolano, Sonsoles Salto-Alejandre, Carmen Infante-Domínguez, Marta Carretero-Ledesma, Natalia Maldonado-Lizarazo, Pedro Camacho-Martínez, Francisco Martín-Domínguez, Inmaculada Tallón-Ruiz, Ana Ruiz-Molina, Zaira Palacios-Baena, Patricia Pérez-Palacios, María Paniagua-García, Rocío Álvarez-Marín, Laura Merino, José Miguel Cisneros, Elisa Cordero, Jerónimo Pachón, José Antonio Pérez-Simón, Javier Sánchez-Céspedes, Manuela Aguilar-Guisado
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2024-09-01
Sarja:International Journal of Infectious Diseases
Aiheet:
COVID-19
SARS-CoV-2
RNAemia
Haematologic malignancies
Clinical outcome
Linkit:http://www.sciencedirect.com/science/article/pii/S1201971224002340
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia